Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ETHK LabsHKSE:01931 74 EV-to-FCF is -2.39 as of Aug. 04, 2026. GuruFocus rates HKSE:01931 with a GF Score™ of 74/100 and a GF Value™ of HK$1.38 (Possible Value Trap). The stock has 9 warning signs investors should review. Among 70 Medical Distribution companies, ETHK Labs ranks worse than 1428570% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, ETHK Labs's Enterprise Value is HK$2,614 Mil.
ETHK Labs's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-1,094 Mil. Therefore, ETHK Labs's EV-to-FCF for today is -2.39.
The historical rank and industry rank for ETHK Labs's EV-to-FCF or its related term are showing as below:
HKSE:01931'
s EV-to-FCF Range Over the Past 10 Years
Min: -264.9 Med: 7.98 Max: 97.46
Current: -2.39
During the past 10 years, the highest EV-to-FCF of ETHK Labs was 97.46. The lowest was -264.90. And the median was 7.98.
HKSE:01931's EV-to-FCF is ranked worse than 100% of 70
companies
in the Medical Distribution industry
Industry Median: 16.755
vs HKSE:01931: -2.39
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
ETHK Labs's share price for today is HK$0.59.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. ETHK Labs's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.023.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
ETHK Labs EV-to-FCF Related Terms
ETHK Labs EV-to-FCF Historical Data
* Premium members only.
The historical data trend for ETHK Labs's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, ETHK Labs's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ETHK Labs EV-to-FCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, ETHK Labs's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where ETHK Labs's EV-to-FCF falls into.
ETHK Labs's current Enterprise Value is HK$2,614 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. ETHK Labs's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-1,094 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ETHK Labs (HKSE:01931) has a EV-to-FCF of -2.39 as of Aug. 04, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on ETHK Labs and its competitors. According to the industry distribution chart, ETHK Labs ranks #999999 out of 70 companies in the Medical Distribution industry.
Is ETHK Labs' EV-to-FCF too high?
ETHK Labs' current EV-to-FCF is -2.39. Based on the distribution chart, ETHK Labs ranks #999999 out of 70 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, ETHK Labs has a GF Score™ of 74/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does ETHK Labs' EV-to-FCF compare to MCK and COR?
According to the Medical Distribution industry distribution chart, ETHK Labs ranks #999999 out of 70 companies for EV-to-FCF. This places ETHK Labs in the lower half of its industry. The industry median EV-to-FCF is 16.76. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Distribution company?
The median EV-to-FCF among Medical Distribution companies is 16.76, based on 70 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on ETHK Labs and its competitors. For the Medical Distribution industry, the median EV-to-FCF is 16.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ETHK Labs's current EV-to-FCF is -2.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ETHK Labs stock overvalued right now?
Based on GuruFocus' analysis, ETHK Labs (HKSE:01931) is currently considered Possible Value Trap. The stock's GF Value™ is HK$1.38, compared to a current price of HK$0.59 — trading 57.2% below its estimated fair value. The current EV-to-FCF is -2.39. ETHK Labs' overall GF Score™ is 74/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For ETHK Labs (HKSE:01931), the current EV-to-FCF is -2.39 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ETHK Labs (HKSE:01931) Overvalued in 2026?
Based on GuruFocus' analysis, ETHK Labs stock appears to be undervalued.
The current stock price of HK$0.59 is trading 57.2% below its estimated GF Value™ of HK$1.38.
GuruFocus considers ETHK Labs to be Possible Value Trap.
Key valuation signals for HKSE:01931:
EV-to-FCF: -2.39
GF Value™: HK$1.38 vs. price of HK$0.59 (57.2% below fair value)
No single metric tells the full story. See the HKSE:01931 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ETHK Labs Inc is engaged in the distribution, after-sales service, and development of in-vitro diagnostic (IVD) products in China. The company operates through three business segments: Distribution Business, After-sales Services, and Self-branded Products Business. It distributes IVD analysers, reagents, and consumables to hospitals and healthcare institutions, provides maintenance and installation services for diagnostic equipment, and develops and sells self-branded IVD analysers and reagents. The company generates the majority of its revenue from Mainland China.
74GF Score
Get the complete analysis for HKSE:01931
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01931 has been successfully added to your 
